சுகாதாரம் · Ebola vaccine trial · காப்பகம்First volunteer receives Ebola Bundibugyo strain vaccine in trialஎழுத்து வடிவம் 7 செப்டம்பர், 2026 அன்று 9:22 PM UTCபாருங்கள்உரைப்பதிவு0:00We begin with a historic step in the0:02fight against a deadly Ebola outbreak.0:04For the first time, a volunteer has0:06received a vaccine against the0:07Bundibugyo strain, which has no approved0:09treatment and has killed more than 1,4000:11people across Central Africa. The0:13timeline shows the rapid response since0:15the May emergency declaration.0:19The phase I safety trial, led by the0:22Oxford Vaccine Group, is enrolling 500:24healthy adults. But with 3,200 cases and0:27over 1,400 deaths, the need is urgent.0:30The World Health Organization alerted0:32the world in May, and today's milestone0:34reflects a sprint by scientists. These0:36facts show the scale of the crisis and0:38the trial's starting point.0:42The same platform was used for COVID-190:44vaccines, adapted now for Bundibugyo.0:48CEPI's Hatchett calls the trial a vital0:50step, while Hunt becomes the first to0:52test the vaccine.0:54It will be months before results are0:55known, and distributing any successful0:57vaccine to remote outbreak zones remains1:00a huge challenge. But today, a historic1:02first dose brings guarded hope.கட்டுரையைப் படிக்கவும்செய்தியின் காலவரிசைHeyDexகுறுங்காணொளி ↗
